US Broker Ratings

United Therapeutics Corporation (UTHR) Stock Analysis: Promising Upside with 12.65% Potential Growth

United Therapeutics Corporation (NASDAQ: UTHR) stands out in the healthcare sector with its innovative focus on addressing unmet medical needs, particularly within the realm of chronic and life-threatening diseases. As..

Royalty Pharma plc (RPRX) Stock Analysis: Exploring a 8.10% Potential Upside with Analyst Confidence

For investors eyeing the biotechnology sector, Royalty Pharma plc (NASDAQ: RPRX) provides an intriguing opportunity. With a market capitalization of $27.71 billion, this New York-based company has carved out a..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Unlocking a 9.38% Upside Potential in the Healthcare Sector

Smith & Nephew SNATS, Inc. (NYSE: SNN), a prominent player in the healthcare sector, particularly within the medical devices industry, offers investors a unique blend of stability and growth potential...

BeOne Medicines Ltd. (ONC) Stock Analysis: A 31.82% Upside Potential Ignites Investor Interest

BeOne Medicines Ltd. (ONC), a burgeoning force in the biotechnology sector, is capturing investor attention with its promising oncology treatments and robust growth metrics. Based in Basel, Switzerland, this healthcare..

Incyte Corporation (INCY) Stock Analysis: Exploring the 11.66% Upside Potential

Incyte Corporation (NASDAQ: INCY), a biopharmaceutical powerhouse in the healthcare sector, continues to capture investor attention with its promising growth trajectory and robust pipeline of therapeutics. With a current market..

Agilent Technologies, Inc. (A) Stock Analysis: Exploring the 40.74% Potential Upside

Agilent Technologies, Inc. (NYSE: A), a prominent player in the healthcare sector, is garnering significant attention from investors, particularly for its robust position within the diagnostics and research industry. With..

Exact Sciences Corporation (EXAS) Stock Analysis: Navigating High Growth in Healthcare Diagnostics

Exact Sciences Corporation (NASDAQ: EXAS) continues to attract investor interest with its robust growth trajectory in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization..

Haleon plc (HLN) Stock Analysis: Unpacking a Potential 22.64% Upside for Investors

Haleon plc (HLN), a prominent player in the healthcare sector, is making waves in the drug manufacturing industry, particularly in the specialty and generic segments. With a substantial market capitalization..

Novartis AG (NVS) Stock Analysis: Navigating a 3.08% Dividend Yield Amidst a Challenging Market Landscape

Novartis AG (NYSE: NVS), a behemoth in the healthcare sector, continues to capture investor attention with its $297.35 billion market capitalization. Known for its robust product pipeline and strategic innovations,..

ResMed Inc. (RMD) Stock Analysis: Exploring a 29.56% Upside Potential with Robust Revenue Growth

ResMed Inc. (NYSE: RMD), a key player in the healthcare sector, stands out in the medical instruments and supplies industry with its innovative approach to managing respiratory disorders. With a..

McKesson Corporation (MCK): Investor Outlook on a Healthcare Giant with a 14.56% Potential Upside

McKesson Corporation (NYSE: MCK) stands as a formidable player in the healthcare sector, primarily operating in the medical distribution industry. With a market capitalization of $106.84 billion, McKesson is a..

Vertex Pharmaceuticals (VRTX) Stock Analysis: A Biotech Gem with 25.71% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), a titan in the biotechnology sector, stands out as a compelling investment opportunity. With a robust market capitalization of $110.97 billion, Vertex continues to dominate..

Universal Health Services, Inc. (UHS) Stock Analysis: Exploring a Potential 37.61% Upside for Investors

Universal Health Services, Inc. (NYSE: UHS), a notable player in the healthcare sector, has been capturing investor attention with its diverse portfolio of medical care facilities. Headquartered in King of..

AbbVie Inc. (ABBV) Stock Analysis: A Deep Dive into a Promising 19.76% Potential Upside

AbbVie Inc. (NYSE: ABBV), a powerhouse in the healthcare sector, continues to capture investor attention with its robust market presence and promising financial outlook. With a market capitalization of $367.8..

Biogen Inc. (BIIB) Stock Analysis: Assessing the 19.67% Potential Upside for Investors

Biogen Inc. (NASDAQ: BIIB), a leading player in the healthcare sector, stands at a pivotal junction for investors seeking to capitalize on its position within the drug manufacturing industry. With..

Genmab A/S (GMAB) Stock Analysis: Potential Upside of Over 31% Amid Strong Buy Ratings

Genmab A/S (GMAB), a prominent player in the biotechnology sector, is capturing investor attention with its robust pipeline and strong market presence. Based in Denmark, the company specializes in developing..

Centene Corporation (CNC) Stock Analysis: Navigating the Healthcare Giant’s 16.07% Potential Upside

Centene Corporation (NYSE: CNC) is a formidable presence in the healthcare sector, known for its comprehensive managed care offerings across Medicaid, Medicare, and commercial segments. Headquartered in Saint Louis, Missouri,..

Waters Corporation (WAT) Stock Analysis: A 21% Upside Potential Amid Robust Growth Prospects

Waters Corporation (NYSE: WAT), a key player in the healthcare sector specializing in diagnostics and research, offers a tantalizing opportunity for investors seeking exposure to cutting-edge analytical technologies. With a..

Quest Diagnostics (DGX) Stock Analysis: Uncovering a 13.77% Upside Potential

Quest Diagnostics Incorporated (NYSE: DGX), a prominent player in the healthcare sector, has established itself as a leader in the diagnostics and research industry. Headquartered in Secaucus, New Jersey, Quest..

Labcorp Holdings Inc. (LH) Stock Analysis: Exploring the 18.60% Potential Upside for Investors

Labcorp Holdings Inc. (NYSE: LH) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Burlington, North Carolina, Labcorp’s extensive range of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds